Nexgel Has Executed A Supply Agreement With AbbVie To Be A Supplier Of Gel Pads To Be Used With AbbVie's Rapid Acoustic Pulse Device Being Investigated For Improvement In The Appearance Of Cellulite
Portfolio Pulse from Benzinga Newsdesk
Nexgel has signed a supply agreement with AbbVie to provide gel pads for AbbVie's Rapid Acoustic Pulse device, which is currently under investigation for its potential to improve the appearance of cellulite.
October 30, 2023 | 12:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
AbbVie has entered into a supply agreement with Nexgel for gel pads to be used with its Rapid Acoustic Pulse device.
The supply agreement with Nexgel is a positive development for AbbVie as it ensures the supply of a key component for its Rapid Acoustic Pulse device. This could potentially lead to positive outcomes in the device's investigation and eventual market success, which would be beneficial for AbbVie's stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Nexgel has secured a supply agreement with AbbVie to provide gel pads for AbbVie's Rapid Acoustic Pulse device.
The supply agreement with AbbVie is a positive development for Nexgel as it secures a steady demand for its gel pads. This could potentially lead to increased revenues and profitability for Nexgel, which would be beneficial for its stock.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80